Alere Receives FDA Clearance for Alere i Influenza A & B 2 Rapid Molecular Test

Alere announced that its Alere i Influenza A & B 2 test has received 510(k) marketing clearance from the U.S. Food and Drug Administration for the detection of influenza A and B infection in children and adults